Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
TYK2 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 1.38E3 | Evidence | |||||
TYK2 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 1.17E3 | Evidence | |||||
TYK2 | CSK | CSK: Tyrosine-protein kinase CSK | 1.17E3 | Evidence | |||||
TYK2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 835.0 | Evidence | |||||
TYK2 | SYK | SYK: Tyrosine-protein kinase SYK | 720.0 | Evidence | |||||
TYK2 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 720.0 | Evidence | |||||
TYK2 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 626.0 | Evidence | |||||
TYK2 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 613.0 | Evidence | |||||
TYK2 | LYN | LYN: Tyrosine-protein kinase Lyn | 613.0 | Evidence | |||||
TYK2 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 613.0 | Evidence | |||||
TYK2 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 506.0 | Evidence | |||||
TYK2 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 497.0 | Evidence | |||||
TYK2 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 445.0 | Evidence | |||||
TYK2 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 416.0 | Evidence | |||||
TYK2 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 407.0 | Evidence | |||||
TYK2 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 392.0 | Evidence | |||||
TYK2 | HCK | N/A | 370.0 | Evidence | |||||
TYK2 | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 370.0 | Evidence | |||||
TYK2 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 364.0 | Evidence | |||||
TYK2 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
TYK2 | JAK1 | 268.0 | Evidence | ||||||
TYK2 | CRKL | CRKL: Crk-like protein | 268.0 | Evidence | |||||
TYK2 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 263.0 | Evidence | |||||
TYK2 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 221.0 | Evidence | |||||
TYK2 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 206.0 | Evidence | |||||
TYK2 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 194.0 | Evidence | |||||
TYK2 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 178.0 | Evidence | |||||
TYK2 | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 165.0 | Evidence | |||||
TYK2 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 162.0 | Evidence | |||||
TYK2 | APS | SH2B2, APS: SH2B adapter protein 2 | 161.0 | Evidence | |||||
TYK2 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 149.0 | Evidence | |||||
TYK2 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 149.0 | Evidence | |||||
TYK2 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 148.0 | Evidence | |||||
TYK2 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 139.0 | Evidence | |||||
TYK2 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence | |||||
TYK2 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 137.0 | Evidence | |||||
TYK2 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence | |||||
TYK2 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 134.0 | Evidence | |||||
TYK2 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 121.0 | Evidence | |||||
TYK2 | STAT3 | 119.0 | Evidence | ||||||
TYK2 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence | |||||
TYK2 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 106.0 | Evidence | |||||
TYK2 | WASPIP | N/A | 101.0 | Evidence | |||||
TYK2 | DOK1 | DOK1: Docking protein 1 | 91.10 | Evidence | |||||
TYK2 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 90.80 | Evidence | |||||
TYK2 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 87.80 | Evidence | |||||
TYK2 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 80.00 | Evidence | |||||
TYK2 | INSR | INSR: Insulin receptor precursor | 80.00 | Evidence | |||||
TYK2 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 79.90 | Evidence | |||||
TYK2 | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 79.40 | Evidence | |||||
TYK2 | SNX17 | SNX17, KIAA0064: Sorting nexin-17 | 69.40 | Evidence | |||||
TYK2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 69.40 | Evidence | |||||
TYK2 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 59.50 | Evidence | |||||
TYK2 | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 58.60 | Evidence | |||||
TYK2 | GRAP | GRAP: GRB2-related adapter protein | 55.80 | Evidence | |||||
TYK2 | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 53.30 | Evidence | |||||
TYK2 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 53.3 | Evidence | |||||
TYK2 | PSMA5 | PSMA5: Proteasome subunit alpha type-5 | 53.3 | Evidence | |||||
TYK2 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 52.50 | Evidence | |||||
TYK2 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 46.90 | Evidence | |||||
TYK2 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 46.90 | Evidence | |||||
TYK2 | PSMA2 | PSMA2, PSC3: Proteasome subunit alpha type-2 | 43.00 | Evidence | |||||
TYK2 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 42.00 | Evidence | |||||
TYK2 | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 36.30 | Evidence | |||||
TYK2 | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 35.00 | Evidence | |||||
TYK2 | ACTG1 | ACTB: Actin, cytoplasmic 1 | 35.00 | Evidence | |||||
TYK2 | NRBP1 | NRBP1, BCON3, NRBP: Nuclear receptor-binding protein | 33.90 | Evidence | |||||
TYK2 | HNRPK | N/A | 32.90 | Evidence | |||||
TYK2 | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 32.70 | Evidence | |||||
TYK2 | TGFB1 | TGFB1, TGFB: Transforming growth factor beta-1 precursor | 28.90 | Evidence | |||||
TYK2 | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 27.90 | Evidence | |||||
TYK2 | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 26.70 | Evidence | |||||
TYK2 | ARHGDIB | ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 | 25.00 | Evidence | |||||
TYK2 | QARS | QARS: Glutaminyl-tRNA synthetase | 25.00 | Evidence |